All News

    How a Blood Test May Help Guide Breast Cancer Treatment

    June 24th 2025, 5:00pm

    Article

    Dr. Rita Mukhtar sits down for a conversation with Dr. Joshua Sabari to discuss the potential use of ctDNA to guide breast cancer therapy.

    What Breast Cancer Taught Me About Saying Yes to the Picture

    June 24th 2025, 4:00pm

    Article

    After two bouts of breast cancer and a double mastectomy, I wish I had taken that photo at 34, just for me to remember the body I once had.

    Daraxonrasib Gains FDA Status for Certain Metastatic Pancreatic Cancer

    June 24th 2025, 3:00pm

    Article

    Daraxonrasib has received breakthrough therapy designation from the FDA for KRAS G12+, previously treated, metastatic pancreatic ductal adenocarcinoma.

    Providing Advocacy and Support for Those With Pediatric Brain Cancer

    June 24th 2025, 1:00pm

    Video

    Kasey Rangan discusses ways that families of patients with pediatric brain cancer can advocate for themselves, especially when it comes to mental health.

    A New Digital Platform Aims to Expand Access to Early Oncology Trials

    June 23rd 2025, 7:00pm

    Article

    The START Hope Hub is a robust digital platform designed to break down barriers to early-phase clinical trial access for those with cancer.

    FDA Approves Datroway for EGFR-Mutated Advanced Lung Cancer

    June 23rd 2025, 6:29pm

    Article

    Datroway received accelerated FDA approval for adults with EGFR+ advanced non-small cell lung cancer after EGFR-targeted and platinum chemotherapy.

    Living My Best Life: A Family Beach Vacation After a Brain Tumor

    June 23rd 2025, 5:00pm

    Article

    After a brain tumor diagnosis and infection, I celebrate recovery with family at the beach, embracing life’s precious moments together.

    Spotlighting Pancreatic Cancer Disparities in Black Communities

    June 23rd 2025, 4:14pm

    Article

    Tripp Razor highlights the disproportionately high pancreatic cancer risk among Black Americans and the systemic disparities they face in access to care.

    Illuccix is FDA Approved to Guide Radioligand Use in Prostate Cancer

    June 23rd 2025, 3:00pm

    Article

    Illuccix is now FDA approved to help select patients with metastatic prostate cancer for radioligand therapy before chemotherapy.

    What Should Patients with Multiple Myeloma Know After ASCO 2025?

    June 23rd 2025, 1:00pm

    Video

    Dr. Joshua Sabari and Dr. Nausheen Ahmed sat down to discuss topline takeaways in the realm of hematologic malignancies following the 2025 ASCO Meeting.